Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-18T15:09:05.261Z Has data issue: false hasContentIssue false

13 - Therapeutic decision making in BMT/SCT for renal cell cancer

Published online by Cambridge University Press:  31 July 2009

Reinhold Munker ,
Hillard M. Lazarus  and
Kerry Atkinson
By
Richard W. Childs
Reinhold Munker
Affiliation:
Louisiana State University
Hillard M. Lazarus
Affiliation:
University Hospitals Case Medical Center
Kerry Atkinson
Affiliation:
University of Queensland
Get access
Type
Chapter
Information
The BMT Data Book , pp. 177 - 188
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Artz, AS, Besien, K, Zimmerman, T, et al. 2005. Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago experience. Bone Marr Transp 35: 253–60.CrossRefGoogle ScholarPubMed
Barkholt, L, Bregni, M, Remberger, M, et al. 2006. Allogeneic haematopoietic stem cell transplantation for metastatic renal cell carcinoma in Europe. Ann Oncol 17: 1134–40.CrossRefGoogle Scholar
Bregni, M, Dodero, A, Peccatori, J, et al. 2002. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 99: 4234–36.CrossRefGoogle ScholarPubMed
Childs, RW, Clave, E, Tisdale, J, et al. 1999. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect. J Clin Oncol 17:2044–49.CrossRefGoogle ScholarPubMed
Childs, R, Chernoff, A, Contentin, N, et al. 2000. Regression of metastatic renal-cell carcinoma after nonmyeloablative peripheral-blood stem-cell transplantation. N Engl J Med 343: 750–58.CrossRefGoogle Scholar
Conrad, R, Remberger, M, Cederlund, K, et al. 2006. Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer. Biol Blood Marr Transplant 12: 346–54.CrossRefGoogle ScholarPubMed
Gommersall, L, Hayne, D, Lynch, C, et al. 2004. Allogeneic stem-cell transplantation for renal cell cancer. Lancet Oncol 5: 561–67.CrossRefGoogle ScholarPubMed
Igarashi, T, Wynberg, J, Srinivasan, R, et al. 2004. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 104: 170–77.CrossRefGoogle ScholarPubMed
Lundqvist, AJ, McCoy, P, Samsel, L, Childs, R. 2007. Reduction of GVHD and enhanced anti-tumor effects after adoptive infusion of alloreactive NK-cells from MHC matched donors. Blood 109: 3603–06.CrossRefGoogle Scholar
Rini, BI, Campbell, SC, Rathmell, WK. 2006. Renal cell carcinoma. Curr Opin Oncol 18: 289–96.CrossRefGoogle ScholarPubMed
Rini, BI, Zimmerman, T, Stadler, WM, et al. 2002: Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. J Clin Oncol 20: 2017–24.CrossRefGoogle ScholarPubMed
Rini, BI, Halabi, S, Barrier, R, et al. 2006. Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study. Biol Blood Marr Transpl. 12: 778–85.CrossRefGoogle ScholarPubMed
Schöffski, P, Dumez, H, Clement, P, et al. 2006. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review. Ann Oncol 17: 1185–96.CrossRefGoogle ScholarPubMed
Srinivasan, R, Carrington, M, Suffredini, D, et al. 2006. Impact of KIR and HLA genotypes on outcome in nonmyeloablative hematopoietic cell transplantation (HCT) using HLA matched related donors. Blood 108: 323a.Google Scholar
Storb, RF, Lucarelli, G, McSweeney, PA, et al. 2003. Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology (Am Soc Hematol Educ Program): 372–97.CrossRefGoogle ScholarPubMed
Takahashi, Y, Childs, RW. 2004. Nonmyeloablative transplantationClin Cancer Res 10: 6353S-59S.CrossRefGoogle ScholarPubMed
Takahashi, Y, Harashima, N, Kajigaya, S, et al. 2008. Regression of human kidney cancer following allogenic stem cell transplantation is associated with recognition of an HERVE antigen by T cells. J Clin Invest 118: 1099–109.CrossRefGoogle Scholar
Tykodi, SS, Warren, EH, Thompson, JA, et al. 2004. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Canc Res 10: 7799–811.CrossRefGoogle ScholarPubMed
Yang, JC, Childs, R. 2006. Immunotherapy for renal cell cancer. J Clin Oncol 24: 5576–83.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×